BA
CHE icon

Boston Advisors’s Chemed CHE Stock Holding History

Boston Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.3M Sell
5,508
-1,235
-18% -$504K 0.12% 227
2019
Q2 		$2.43M Sell
6,743
-1,055
-14% -$353K 0.13% 200
2019
Q1 		$2.5M Sell
7,798
-12,469
-62% -$3.83M 0.13% 199
2018
Q4 		$5.74M Buy
20,267
+1,278
+7% +$386K 0.33% 77
2018
Q3 		$6.07M Sell
18,989
-3,433
-15% -$1.09M 0.26% 112
2018
Q2 		$7.22M Sell
22,422
-72
-0.3% -$22.5K 0.18% 109
2018
Q1 		$6.14M Buy
22,494
+505
+2% +$134K 0.16% 136
2017
Q4 		$5.34M Buy
21,989
+14,153
+181% +$3.21M 0.12% 205
2017
Q3 		$1.58M Sell
7,836
-688
-8% -$135K 0.04% 308
2017
Q2 		$1.74M Sell
8,524
-1,911
-18% -$381K 0.04% 311
2017
Q1 		$1.91M Buy
+10,435
New +$1.82M 0.04% 289
2015
Q2 		– Sell
-1,850
Closed -$221K – 656
2015
Q1 		$221K Buy
+1,850
New +$205K 0.01% 624

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Advisors's CHE Position: Q3 2019 in Review

Boston Advisors reduced its Chemed (CHE) stake by 18% in Q3 2019, selling an estimated $504K and leaving 5,508 shares worth $2.3M. The position accounts for 0.12% of the portfolio, ranked #227.

Boston Advisors first reported a position in CHE in Q1 2015 and has held it in 12 quarters since. The position peaked at $7.22M in Q2 2018. 393 funds tracked by Wall St. Rank hold CHE as of Q3 2019.

  • Boston Advisors held 5,508 shares of Chemed worth $2.3M as of Q3 2019.
  • Boston Advisors sold 1,235 Chemed shares in Q3 2019, an estimated $504K.
  • Chemed made up 0.12% of Boston Advisors's portfolio in Q3 2019, its #227 holding.
  • Boston Advisors first reported a position in Chemed in Q1 2015 and has held it in 12 quarters since.
  • Boston Advisors's Chemed position peaked at $7.22M in Q2 2018.
  • 393 funds tracked by Wall St. Rank held Chemed as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.